The majority of colonic cancers seen in LS patients have a proximal predilection for site of occurrence and affect the right colon [6], while rectal cancer (left-sided) is seen in ~20% of MLH1 and MSH2 carriers [2]. The gene discussed is MSH2; the disease is rectal cancer.